Bn. La Du et al., Serum paraoxonase (PON1) isozymes: The quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals, DRUG META D, 29(4), 2001, pp. 566-569
In a recent study on Gulf War veterans who developed delayed neurotoxicity
symptoms, we found their levels of serum paraoxonase (PON1) isozyme type Q
to be significantly lower than in the control, unaffected veteran group. Th
ese results were obtained in 25 ill veterans and 20 well control subjects,
of which 10 were deployed and 10 were nondeployed battalion members who rem
ained in the United States during the Gulf War. The blood samples were also
assayed for serum butyrylcholinesterase in our laboratory, and more recent
ly in Dr. C. Broomfield's laboratory for somanase and sarinase activities.
The cholinesterase activities showed no significant correlation with the PO
N1 isozyme levels or the severity of the clinical symptoms, but the somanas
e and sarinase levels ran parallel to the PON1 type Q isozyme concentration
s. Although there is no direct evidence that these Gulf War veterans were d
irectly exposed to or encountered either of these nerve gases, they may hav
e been exposed to some environmental or chemical toxin with a similar prefe
rence for hydrolysis by the PON1 type Q isozyme. The number of subjects is
relatively small, but the results should encourage other investigators to e
xamine both the individual phenotypes and the levels of PON1 isozymes in ot
her groups exhibiting neurological symptoms.